CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Chongqing Taiji Industry (Group) Company Snapshot
Chongqing Taiji Industry (Group) operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Taiji Industry (Group) with three other companies in this sector in China: Livzon Pharmaceutical Group Incorporated (2016 sales of 7.65 billion Chinese Renmimbi [US$1.13 billion] of which 42% was Western Medicine), Huapont-Nutrichem Co Ltd (7.09 billion Chinese Renmimbi [US$1.05 billion] of which 68% was Agricultural Business), and North China Pharmaceutical, Limited (8.08 billion Chinese Renmimbi [US$1.20 billion] of which 43% was Chemical Preparation Medicine).

Sales Analysis. During the year ended December of 2016, sales at Chongqing Taiji Industry (Group) were 7.78 billion Chinese Renmimbi (US$1.15 billion). This is an increase of 8.7% versus 2015, when the company's sales were 7.16 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Chongqing Taiji Industry (Group) (and since 2011, sales have increased a total of 22%). Sales of Industrial saw an increase that was more than double the company's growth rate: sales were up 18.8% in 2016, from 3.04 billion Chinese Renmimbi to 3.61 billion Chinese Renmimbi. Not all segments of Chongqing Taiji Industry (Group) experienced an increase in sales in 2016: sales of Other fell 19.2% to 109.19 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Chongqing Taiji Industry (Group) also experienced decreases in sales in Service (down 9.3% to 11.54 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Chongqing Taiji Industry (Group)
  Stock Performance Chart for Chongqing Taiji Industry (Group)
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 14.14
(Figures in Chinese Renmimbi)
1 Week 4.8%   13 Weeks 6.1%  
4 Weeks -20.2%   52 Weeks -23.7%  
 
Chongqing Taiji Industry (Group) Key Data:
  Ticker: 600129 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 7,782,324,066
(Year Ending Jan 2017).
Employees: 14,363
  Currency: Chinese Renmimbi Market Cap: 6,036,281,160
  Fiscal Yr Ends: December Shares Outstanding: 426,894,000
  Share Type: A Gu Closely Held Shares: 195,777,176
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.